iTeos Therapeutics, Inc.
ITOS
$7.77
$0.273.60%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -34.61M | -43.71M | -45.36M | -7.13M | -38.22M |
| Total Depreciation and Amortization | 324.00K | 322.00K | 302.00K | 310.00K | 304.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.22M | 486.00K | 6.07M | 5.27M | 4.52M |
| Change in Net Operating Assets | -4.69M | 48.40M | 1.64M | -32.38M | 990.00K |
| Cash from Operations | -33.76M | 5.50M | -37.35M | -33.93M | -32.40M |
| Capital Expenditure | -101.00K | -152.00K | -94.00K | -442.00K | -945.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 47.79M | 13.77M | -91.40M | 16.76M | -68.66M |
| Cash from Investing | 47.69M | 13.62M | -91.49M | 16.32M | -69.60M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 32.00K | 274.00K | 46.00K | 122.38M | 22.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 11.00K | -488.00K | -- | -- |
| Cash from Financing | 32.00K | 285.00K | -442.00K | 122.38M | 22.00K |
| Foreign Exchange rate Adjustments | 459.00K | -1.02M | 1.94M | -289.00K | -2.55M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.42M | 18.38M | -127.35M | 104.48M | -104.53M |